Pharmacokinetics of Erlotinib and Its Active Metabolite OSI-420 in Patients with Non-small Cell Lung Cancer and Chronic Renal Failure Who Are Undergoing Hemodialysis
暂无分享,去创建一个
Young Hak Kim | M. Mishima | M. Fukudo | T. Mio | K. Inui | S. Fujita | T. Terada | Y. Ikemi | K. Masago | K. Irisa | Y. Sakamori | Y. Togashi | Y. H. Kim